Zimmer Biomet reported Q2 2025 earnings with revenue of $2.077 billion, beating analyst estimates. The company saw strong growth in Sports Medicine, Extremities, and Trauma (S.E.T.) segment, raised full-year guidance, and continues to focus on robotic and digital surgery innovations.

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for three companies: Sonnet BioTherapeutics, First Community Corporation, and Monogram Technologies, related to their recent merger or sale transactions.

Zimmer Biomet will acquire Monogram Technologies for $177 million, gaining advanced AI-assisted robotic knee technology with potential for fully autonomous surgical robotics, expected to enhance orthopedic surgical capabilities.

Monogram Orthopaedics, Flowers Foods, Farfetch and Applied Materials are among stocks on the move for Friday.